CIS Is First in the Area to Use the Lightning Bolt™ 7 System to Remove Blood Clots in the Legs

 Lightning 7

Pictured from left to right are Taylor McBride (RN); Chad Thompson (RN); Kevin Latiolais R.T. (R) RCIS; Theresa Cannon R.T. (R); Dr. Kalyan Veerina; Lauren Hebert with Penumbra; and Layla Davis R.T. (R).

OPELOUSAS – Dr. Kalyan Veerina, interventional cardiologist at Cardiovascular Institute of the South (CIS) in Opelousas, is the first in the area to use the Lightning Bolt™ 7 system by Penumbra, Inc. to extract blood clots quickly and efficiently from peripheral arteries. The procedure was performed at Opelousas General Health System.

These types of blood clots oftentimes require invasive open surgery to remove, or in severe cases, they can result in amputation. However, the minimally-invasive Lightning Bolt™ 7 system uses a computer-aided clot detection technology that modulates aspiration, which is designed to speed up clot removal while leaving healthy blood circulating.

“This new technology allows us to aspirate blood clots within minutes, treating limb- and life-threatening clots more quickly,” said Dr. Veerina. “We are proud to offer this new treatment in Opelousas to restore our patients’ health and help to improve their quality of life.”

Lightning Bolt 7, which was cleared by the US Food and Drug Administration (FDA) and became available in March, addresses conditions such as acute limb ischemia (ALI), hibernating thrombus and visceral occlusions. It is part of Penumbra’s Indigo System with Lightning portfolio, which are the only computer-aided mechanical thrombectomy systems currently available in the U.S. Prior to the availability of Lightning Bolt 7, recent data with the Indigo System have shown excellent 30-day limb salvage rates in more than 98% of patients, short procedure times with an average of 22 minutes and low 30-day mortality at 3%.

For risks and more information please see:

For an appointment with a CIS cardiologist, click below.



Latest News

CIS Staff

Written by CIS Staff